PhRMA

Congress should make sure savings on medicines go to patients, not PBMs. https://lnkd.in/eg_x6As7

Eli Lilly and Company CEO Dave Ricks explains the dangers of the current administration’s proposed march-in rights framework on the pharmaceutical industry’s ability to develop new cancer treatments and cures and deliver them to patients like those with pancreatic cancer. #PancreaticCancerAwarenessMonth

This #NationalFamilyCaregiversMonth is a moment to recognize the substantial toll that Alzheimer’s disease has on the loved ones of patients living with this devastating condition. Watch more from Eli Lilly and Company's Anne White & PhRMA's Lori Reilly: https://lnkd.in/eJMDwRfE. #ENDALZ

Vaccines are highly effective and safe tools for protecting our health, with a long history of saving lives and reducing health care costs. Our Chief Medical Officer Dr. Michael Ybarra, MD recently participated in the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices. See his key takeaways here about what was discussed:

According to the latest Patient Experience Survey, out-of-pocket costs lead key health care priorities ahead of the November election. Read more: https://lnkd.in/eCVrERSn

Dr. Michael Ybarra, MD, Chief Medical Officer, highlights the role of policy in: • Lowering out-of-pocket costs. 💵 • Expanding patient access. 🧑🏿🤝🧑🏾 • Safeguarding oncology R&D. 🔬

“I want my doctor to decide my medications, not someone behind a desk at an office who has never met me,” says Renne, who lives in Arizona. On November 5, candidates need to put patients first. No one should have to fight a middleman for their right to breathe. Read more: https://lnkd.in/eFXUsVMf

Americans’ experience with the health care system continues to be defined by access and affordability challenges, and specifically, insurer- and PBM-imposed hurdles, the fifth and newest Patient Experience Survey (PES) reports. Conducted by PhRMA and Ipsos, the latest PES highlights how and why patients demand greater urgency in making meaningful strides toward affordable health care. Key findings include: - Four in 10 (41%) insured Americans taking a prescription medicine have experienced insurer- and PBM-imposed barriers to care. - A third of insured Americans (33%) say their health care out-of-pocket costs for health care services have increased over the past year; about 4 in 10 (38%) of Rx insured patients report an increase in prescription medicine out-of-pocket costs. - Most insured Americans (90%) support cracking down on abusive insurer and PBM practices that can limit patient access to medicines. Dive deeper into the data today, which include robust findings across patient populations, demographics and geographic areas: https://lnkd.in/eKRVF-gq

PhRMA recently had the opportunity to join the Congressional Black Caucus Foundation and Congressional Hispanic Caucus Institute (CHCI) for insightful conversations on how we can drive change toward a more equitable future for communities of color and rural residents. From a conversation on creating a more accessible landscape in clinical trials to redressing barriers to care – the future of health care is here. We’re excited to be at the forefront of improving health outcomes through initiatives like Equitable Breakthroughs in Medicine Development and with our member companies and partners. Amgen, Anthony Coley, Darryl Sleep, MD (MBBCh, FCS(SA)), Tesheia Johnson

PhRMA CMO Dr. Michael Ybarra recently joined MANA A NATIONAL LATINA ORGANIZATION’s President and CEO Amy Hinojosa to discuss the barriers to care that Hispanic patients face at the Congressional Hispanic Caucus Institute (CHCI) Institute’s Leadership Conference. From systemic barriers to not being able to afford health insurance costs, these challenges create significant obstacles to accessing essential health services. Dr. Ybarra highlighted the importance of addressing social determinants of health and advancing policy solutions that improve affordability and access to care.  Together, we must ensure that no patient is left behind, and that health equity becomes a reality for the Hispanic community. Read more about our patient-centered agenda: https://lnkd.in/g8v2nrEV